LOS ANGELES, March 14, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ: NTLA) for violations of §§10(b) and 20(a) of the...
Read More Details
Finally We wish PressBee provided you with enough information of ( NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm )
Also on site :
- Possible tornado in Phelps on Monday
- Bagel Land in Brighton temporarily closed due to sanitary code violation
- Meta reportedly recruits Apple’s head of AI models